Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): High throughput assays in mammalian cells

European Journal of Pharmacology

Volumn 295, Issue 1, 1996, Pages 93-102

  Bräuner Osborne, Hans ^a,b   Brann, Mark R ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

G protein; High throughput assay; Molecular biology; Muscarinic receptor

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ARECOLINE; ATROPINE; BETA GALACTOSIDASE; CARBACHOL; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MARKER; METHOCTRAMINE; MUSCARINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE; PARA FLUOROHEXAHYDROSILADIFENIDOL; PILOCARPINE; PIRENZEPINE; RECEPTOR SUBTYPE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ANIMAL CELL; ARTICLE; ASSAY; CELL PROLIFERATION; CELL STRAIN 3T3; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

EID: 0039410502     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00639-7     Document Type: Article

References (47)

1. Allen, L.F., R.J. Lefkowitz, M.G. Caron and S. Cotecchia, 1991, G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha-1B-adrenergic receptor enhances mitogenesis and tumorigenicity, Proc. Acad. Sci. USA 88, 11354.
2. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. Chemother. 14, 48.
3. Bonner, T.I., N.J. Buckley, A.C. Young and M.R. Brann, 1987, Identification of a family of muscarinic acetylcholine receptor genes, Science 237, 527.
4. Bonner, T.I., A.C. Young, M.R. Brann and N.J. Buckley, 1988. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes, Neuron 1, 403.
5. Brann, M.R., J. Ellis, H. Jørgensen, D. Hill-Eubanks and S.V.P. Jones, 1993, Muscarinic acetylcholine receptor subtypes: localization and structure/function, Prog. Brain Res. 98, 121.
6. Brown, J.H., ed., 1989, The Muscarinic Receptors. (Humana Press, Clifton, New Jersey).
7. Buckley, N.J., T.I. Bonner, C.M. Buckley and M.R. Brann, 1989, Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells, Mol. Pharmacol. 35, 469.
8. q, FEBS Lett. 363, 261.
9. Burstein, E.S., T.A. Spalding, D. Hill-Eubanks and M.R. Brann, 1995b, Structure/function of muscarinic receptor coupling to G proteins: random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins, J. Biol. Chem. 270, 3141.
10. Bymaster, F.B., J.F. Falcone, H.E. Shannon and D.O. Calligaro, 1995, Arachidonic acid release by muscarinic agents in cell lines transfected with muscarinic receptors. Proceedings of Subtypes of Muscarinic Receptors VI. Life Sci. Abstracts 56, 1016.
11. Caulfield, M.P., 1993, Muscarinic receptors - characterization, coupling and function, Pharmacol. Ther. 58, 319.
12. 50) of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
13. ia, Nature 363, 274.
14. Craig, D.A., 1993, The Cheng-Prusoff relationship: something lost in the translation, Trends Pharmacol. Sci. 14, 89.
15. Dörje, F., J. Wess, G. Lambrecht, R. Tacke, E. Mutschier and M.R. Brann, 1991, Antagonist binding profiles of five cloned human muscarinic receptor subtypes, J. Pharmacol. Exp. Ther. 256, 727.4
16. Eltze, M., B. Ullrich, E. Mutschler, U. Moser, E. Bungardt, T. Friebe, C. Gubitz, R. Tacke and G. Lambrecht, 1993, Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney, Eur. J. Pharmacol. 238, 343.
17. Goldman, P.S. and N.M. Nathanson, 1994, Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor, J. Biol. Chem. 269, 15640.
18. Graminski, G.F., C.K. Jayawickreme, M.N. Potenza and M.R. Lerner, 1993, Pigment dispersion in frog melanophores can be induced by a phorbol ester or stimulation of a recombinant receptor that activates phosholipase C, J. Biol. Chem. 268, 5957.
19. Gutkind, J.S., E.A. Novotny, M.R. Brann and K.C. Robbins, 1991, Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes, Proc. Natl. Acad. Sci. USA 88, 4703.
20. Himmler, A., C. Stratowa and A.P. Czernilofsky, 1993, Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines, J. Rec. Res. 13, 79.
21. Jainchill, J.L., S.A. Aaronson and G.J. Todaro, 1969, Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells, J. Virol. 4, 549.
22. Jones, S.V.P., O.H. Choi and M.A. Beaven, 1991, Carbachol induces secretion in a mast cell line (RBL-2H3) transfected with the m1 muscarinic receptor gene, FEBS Lett. 289, 47.
23. Jones, S.V.P., A.I. Levey, D.M. Weiner, J. Ellis, E. Novotny, S.-H. Yu, F. Dörje, J. Wess and M.R. Brann, 1992, Muscarinic acetylcholine receptors, in: Molecular Biology of G-Protein-Coupled Receptors, ed. M.R. Brann (Birkhäuser, Boston) p. 170.
24. Julius, D., Y.J. Livelli, T.M. Jessell and R. Axel, 1989, Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation, Science 244, 1057.
25. Kenakin, T.P. and P.H. Morgan, 1989, Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists, Mol. Pharmacol. 35, 214.
26. s a subunit, Science 250, 121.
27. Kubo, T., K. Fukuda, A. Mikami, A. Maeda, H. Takahashi, T. Mishina, K. Haga, A. Haga, A. Ichiyama, K. Kangawa, M. Kojima, H. Matsuo, T. Hirose and S. Numa, 1986, Cloning sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor, Nature 323, 411.
28. Lazareno, S., T. Farries and N.J.M. Birdsall, 1993, Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4, Proc. Subtypes Muscarinic Receptors V. Life Sci. 52, 449.
29. Levey, A.I., 1993, Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain, Proc. Subtypes Muscarinic Receptors V. Life Sci. 52, 441.
30. Lim, K. and C.-B. Chae, 1989, A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase, BioTechniques 7, 576.
31. McKinney, M., J.H. Miller, V.A. Gibson, L. Nickelson and S. Aksoy, 1991, Interactions of agonists with m2 and m4 muscarinic receptor subtypes mediating cyclic AMP inhibition, Mol. Pharmacol. 40, 1014.
32. Montmayeur, J.-P. and E. Borelli, 1991, Transcription mediated by cAMP-responsive promotor elements is reduced upon activation of dopamine D2 receptors, Proc. Natl. Acad. Sci. USA 88, 3135.
33. Nathanson, N.M., 1987, Molecular properties of the muscarinic acetylcholine receptor, Ann. Rev. Neurosci. 10, 195.
34. Novotny, E. and M.R. Brann, 1989, Agonist pharmacology of cloned muscarinic receptors, Proc. Subtypes Muscarinic Receptors IV. Trends Pharmacol. Sci. 4, Abstr. 66.
35. Okayama, H. and P. Berg, 1983, A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells, Mol. Cell. Biol. 3, 280.
36. Pedder, E.K., P. Eveleigh, D. Poyner, E.C. Hulme and N.J.M. Birdsall, 1991, Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes, Br. J. Pharmacol. 103, 1561.
37. Peralta, E.G., A. Ashkenazi, J.W. Winslow, D.H. Smith, J. Ramachandran and D.J. Capon, 1987, Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors, EMBO J. 6, 3923.
38. s protein-coupled receptors using recombinant melanophore-based bioassay, Anal. Biochem. 206, 315.
39. Richards, M.H. and Van Giersbergen, P.L.M., 1995, Human muscarinic receptors expressed in A9L and CHO cells, activation by full and partial agonists, Br. J. Pharmacol. 114, 1241.
40. Rodbard, D. and D.M. Hutt, 1974, Statistical analysis of radioim-munoassays and immunoradiometric (labelled antibody) assays: a generalized weighted, iterative, least-squares method for logistic curve fitting, in: Radioimmunoassay and Related Procedures in Medicine (International Atomic Energy Agency, Vienna) Vol. 1. p. 165.
41. Schwarz, R., R.E. Davis, J.C. Jaen, C.J. Spencer, H. Tecle and A.J. Thomas, 1993, Characterization of muscarinic agonists in recombinant cell lines, Proc. Subtypes Muscarinic Receptors V. Life Sci. 52, 465.
42. Sokolovsky, M., 1989, Muscarinic cholinergic receptors and their interaction with drugs, Adv. Drug Res. 18, 432.
43. Spalding, T.A., E.S. Burstein, H. Bräuner-Osborne, D. Hill-Eubanks and M.R. Brann, 1995, Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis, J. Pharmacol. Exp. Ther. (in press).
44. Wang, S.Z. and E.E. El-Fakahany, 1993, Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists, J. Pharmacol. Exp. Ther. 266, 237.
45. Wess, J., G. Lambrecht, E. Mutschler, M.R. Brann and F. Dörje, 1991, Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations, Br. J. Pharmacol. 102, 246.
46. 2 receptors to phosholipase C activates a luciferase reporter gene, Rec. Channels 1, 193.
47. Wigler, M., S. Silverstein, L.-S. Lee, A. Pellicer, Y.-C. Cheng and R. Axel, 1977, Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells, Cell 11, 223.